Compare Stocks → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BTECNASDAQ:FTXHNASDAQ:IBBQNASDAQ:MEDX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTECPrincipal Healthcare Innovators ETF$34.30+2.1%$36.97$25.66▼$39.75$40.13M1.015,075 shs2,346 shsFTXHFirst Trust Nasdaq Pharmaceuticals ETF$25.91+0.2%$27.31$23.85▼$28.41$19.43M0.76,262 shs1,704 shsIBBQInvesco Nasdaq Biotechnology ETF$20.70+0.9%$21.73$18.18▼$23.02$30.43M0.6120,123 shs10,554 shsMEDXHorizon Kinetics Medical ETF$27.49-0.1%$29.14$27.02▼$32.16$16.49M0.6987 shs121 shsThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTECPrincipal Healthcare Innovators ETF+2.09%+2.33%-9.81%-4.65%-0.03%FTXHFirst Trust Nasdaq Pharmaceuticals ETF+0.25%+0.19%-7.52%-4.66%-1.59%IBBQInvesco Nasdaq Biotechnology ETF+0.88%+1.82%-7.09%-6.08%-0.14%MEDXHorizon Kinetics Medical ETF-0.07%+0.47%-8.07%-2.90%+2,748,789,900.00%Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTECPrincipal Healthcare Innovators ETFN/AN/AN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTECPrincipal Healthcare Innovators ETF0.00N/A$47.0237.10% UpsideFTXHFirst Trust Nasdaq Pharmaceuticals ETF0.00N/A$32.1424.04% UpsideIBBQInvesco Nasdaq Biotechnology ETF0.00N/A$25.7924.60% UpsideMEDXHorizon Kinetics Medical ETF0.00N/A$37.4736.33% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTECPrincipal Healthcare Innovators ETFN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTECPrincipal Healthcare Innovators ETFN/AN/A16.50∞N/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A15.42∞N/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/A16.24∞N/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A17.23∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTECPrincipal Healthcare Innovators ETF$0.451.31%N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.381.47%N/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETF$0.180.87%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$1.645.97%N/AN/AN/ALatest IBBQ, FTXH, MEDX, and BTEC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024FTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.06763/21/20243/22/20243/28/20243/15/2024IBBQInvesco Nasdaq Biotechnology ETFQuarterly$0.04353/18/20243/19/20243/22/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTECPrincipal Healthcare Innovators ETFN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AMEDXHorizon Kinetics Medical ETF62.18%Insider OwnershipCompanyInsider OwnershipBTECPrincipal Healthcare Innovators ETFN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AMEDXHorizon Kinetics Medical ETF4.30%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBTECPrincipal Healthcare Innovators ETF147,0001.17 millionN/ANot OptionableFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000750,000N/AOptionableIBBQInvesco Nasdaq Biotechnology ETFN/A1.47 millionN/AOptionableMEDXHorizon Kinetics Medical ETFN/A600,000N/ANot OptionableIBBQ, FTXH, MEDX, and BTEC HeadlinesSourceHeadlineHorizon Kinetics ISE Wealth (RCH)uk.investing.com - May 13 at 1:58 AMHORIZON Fushi ChinaA 50 ETF (512150)investing.com - May 11 at 9:22 AMHorizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)finance.yahoo.com - April 19 at 4:49 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsPrincipal Healthcare Innovators ETFNASDAQ:BTECThe Principal Healthcare Innovators ETF (BTEC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to hold equities of small- and mid-cap healthcare firms in the US. The fund uses a proprietary, quantitative model to construct the portfolio. BTEC was launched on Aug 19, 2016 and is managed by Principal.First Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHThe First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Invesco Nasdaq Biotechnology ETFNASDAQ:IBBQThe Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Horizon Kinetics Medical ETFNASDAQ:MEDXThe Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.